Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19107743rdf:typepubmed:Citationlld:pubmed
pubmed-article:19107743lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0205127lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0037663lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0971859lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:19107743lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:19107743pubmed:issue5lld:pubmed
pubmed-article:19107743pubmed:dateCreated2009-4-29lld:pubmed
pubmed-article:19107743pubmed:abstractTextThis study investigated the growth promoting effects of yeast extract (YH) fed to Sprague-Dawley male rats (3 weeks old) for 4 weeks. The negative (N)-control and positive (P)-control groups were given a daily oral administration of saline and foremilk (1 g/kg of BW), respectively, and the YH-1 and YH-2 groups were given daily administrations of YH (0.5 and 1 g/kg of BW, respectively). After 4 weeks, the YH-1, YH-2 and P-control groups showed significant differences in the body weight gain compared with the N-control group (p < 0.05). The YH-1 and YH-2 groups also had significantly different tibial bone growths (0.47 and 0.49 mm/day, respectively) and femur bone growths (0.52 and 0.53 mm/day, respectively) compared with the N-control group (0.37 mm/day of tibial growth and 0.42 mm/day of femur growth) (p < 0.05). The YH-1 and YH-2 groups had significantly different growth plate (proximal epiphysis) height increments (0.62 and 0.56 mm, respectively) compared with the N-control group (0.17 mm) (p < 0.05). Lastly, the YH-1 and YH-2 groups presented different growth hormone (GH) levels (1.77 and 2.10 ng/mL, respectively) than the N-control group (0.82 ng/mL) (p < 0.05). YH administration increased longitudinal bone growth and GH secretion in rats. Consequently, YH may offer an improved ability to treat GH deficiency-related disorders.lld:pubmed
pubmed-article:19107743pubmed:languageenglld:pubmed
pubmed-article:19107743pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19107743pubmed:citationSubsetIMlld:pubmed
pubmed-article:19107743pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19107743pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19107743pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19107743pubmed:statusMEDLINElld:pubmed
pubmed-article:19107743pubmed:monthMaylld:pubmed
pubmed-article:19107743pubmed:issn1099-1573lld:pubmed
pubmed-article:19107743pubmed:authorpubmed-author:KimJung MinJMlld:pubmed
pubmed-article:19107743pubmed:authorpubmed-author:SuhHyung...lld:pubmed
pubmed-article:19107743pubmed:authorpubmed-author:JungEun-Young...lld:pubmed
pubmed-article:19107743pubmed:authorpubmed-author:BaeSong...lld:pubmed
pubmed-article:19107743pubmed:authorpubmed-author:KimSeong-Yeon...lld:pubmed
pubmed-article:19107743pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19107743pubmed:volume23lld:pubmed
pubmed-article:19107743pubmed:ownerNLMlld:pubmed
pubmed-article:19107743pubmed:authorsCompleteYlld:pubmed
pubmed-article:19107743pubmed:pagination731-6lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:meshHeadingpubmed-meshheading:19107743...lld:pubmed
pubmed-article:19107743pubmed:year2009lld:pubmed
pubmed-article:19107743pubmed:articleTitleYeast hydrolysate induces longitudinal bone growth and growth hormone release in rats.lld:pubmed
pubmed-article:19107743pubmed:affiliationDepartment of Radiologic Science, Korea University, Seoul, Korea.lld:pubmed
pubmed-article:19107743pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19107743pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed